You have searched for "Affin Hwang research"
Showing 51-60 of 277
KUALA LUMPUR: Affin Hwang Capital Research reaffirmed its Buy rating on IHH Healthcare with a 12-month discounted cashflow-derived target price of RM7.10.
KUALA LUMPUR: Affin Hwang Capital Research maintained its hold call on Sime Darby Plantation with an unchanged target price of RM5.35 based on an unchanged 25x CY18E core earnings per share following a visit to its estates under PT Aneka Intipersada in Pekanbaru in Indonesia.
KUALA LUMPUR: Affin Hwang Capital Research said HSS Engineers Bhd's tptal new contracts of RM300mil year to date have exceeded its earlier assumptions for FY18E.
PETALING JAYA: In levels not seen since December 2014, Brent crude oil hit US$71.72 as political tensions rose after US President Donald Trump’s tweet that he would fire missiles at Syria in response to a suspected chemical weapon attack.
KUALA LUMPUR: Affin Hwang Capital Research has maintained neutral on the plantation sector with a crude palm oil average selling price assumption of RM2,600 per metrinc tonne for 2018E.
KUALA LUMPUR: Affin Hwang Capital Research is maintaining its Neutral rating on the brewery sector.